Kara Fick Email

Director, Patient Advocacy and Medical Affairs . Atsena Therapeutics

Current Roles

Employees:
41
Revenue:
$3.2M
About
Atsena Therapeutics is a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness. We have an ongoing Phase I/II clinical trial evaluating a potential therapy for one of the most common causes of blindness in children. Our additional pipeline of leading preclinical assets is powered by an adeno-associated virus (AAV) technology platform tailored to overcome significant hurdles presented by inherited retinal disease. Founded by ocular gene therapy pioneers Dr. Shannon Boye and Sanford Boye, Atsena has strong ties with the University of Florida. Our offices are located in Durham, NC and Boston, MA, environments rich in gene therapy expertise.
Atsena Therapeutics Address
701 W Main St
null, null
Atsena Therapeutics Email

Past Companies

Atsena TherapeuticsDirector, Patient Advocacy and Medical Affairs
Friedreich's Ataxia Research Alliance (FARA)Director, Patient Engagement (Consultant)
Taysha Gene TherapiesDirector, Patient Advocacy

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.